Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Lipka DB"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Weichenhan D; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany., Riedel A; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany., Sollier E; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany., Toprak UH; Division of Neuroblastoma Genomics, German Cancer Research Center, Heidelberg, Germany., Hey J; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany., Breuer K; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany., Wierzbinska JA; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany., Touzart A; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany., Lutsik P; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany., Bähr M; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany., Östlund A; Department of Laboratory Medicine, University of Gothenburg, Gothenburg, Sweden., Nilsson T; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden., Jacobsson S; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden., Edler M; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden., Waraky A; Department of Laboratory Medicine, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden., Behrens YL; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Göhring G; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Schlegelberger B; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Steinek C; Faculty of Biology, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany., Harz H; Faculty of Biology, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany., Leonhardt H; Faculty of Biology, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany., Dolnik A; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-University Berlin, Berlin, Germany., Reinhardt D; Department of Pediatric Oncology, University of Duisburg-Essen, Essen, Germany., Bullinger L; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-University Berlin, Berlin, Germany., Palmqvist L; Department of Laboratory Medicine, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden., Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany.; German Cancer Consortium, Heidelberg, Germany.; National Center for Tumor Diseases, NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Plass C; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; German Cancer Consortium, Heidelberg, Germany.
Publikováno v:
Blood advances [Blood Adv] 2024 Oct 08; Vol. 8 (19), pp. 5100-5111.
Autor:
Haage TR; Department of Hematology, Oncology, and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Leipziger Str. 44, 39120, Magdeburg, Germany.; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany., Charakopoulos E; Department of Hematology, Oncology, and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Leipziger Str. 44, 39120, Magdeburg, Germany.; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany., Bhuria V; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany.; Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Center for Health and Medical Prevention - CHaMP, Otto-von-Guericke University, Magdeburg, Germany., Baldauf CK; Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany., Korthals M; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany.; Institute for Biochemistry and Cell Biology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany., Handschuh J; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany.; Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany., Müller P; Department of Hematology, Oncology, and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Leipziger Str. 44, 39120, Magdeburg, Germany.; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany., Li J; Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge, Cambridge, GB, England., Harit K; Institute for Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany., Nishanth G; Institute for Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany., Frey S; Department of Hematology, Oncology, and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Leipziger Str. 44, 39120, Magdeburg, Germany.; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany., Böttcher M; Department of Hematology, Oncology, and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Leipziger Str. 44, 39120, Magdeburg, Germany.; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany., Fischer KD; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany.; Institute for Biochemistry and Cell Biology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany., Dudeck J; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany.; Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany., Dudeck A; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany.; Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany., Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; Faculty of Medicine, Otto-von-Guericke University, Magdeburg, Germany., Schraven B; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany.; Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Center for Health and Medical Prevention - CHaMP, Otto-von-Guericke University, Magdeburg, Germany., Green AR; Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge, Cambridge, GB, England., Müller AJ; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany.; Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Center for Health and Medical Prevention - CHaMP, Otto-von-Guericke University, Magdeburg, Germany.; Helmholtz Centre for Infection Research, Braunschweig, Germany., Mougiakakos D; Department of Hematology, Oncology, and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Leipziger Str. 44, 39120, Magdeburg, Germany.; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany., Fischer T; Healthcampus Immunology, Inflammation and Infectiology (GC-I, Otto-von-Guericke-University, Magdeburg, Germany. thomas.fischer@med.ovgu.de.; Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany. thomas.fischer@med.ovgu.de.; Center for Health and Medical Prevention - CHaMP, Otto-von-Guericke University, Magdeburg, Germany. thomas.fischer@med.ovgu.de.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Jun 09; Vol. 17 (1), pp. 43. Date of Electronic Publication: 2024 Jun 09.
Autor:
Schöpf J; Division of Applied Functional Genomics, German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Uhrig S; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg, and DKFZ, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Heilig CE; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Lee KS; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany., Walther T; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany., Carazzato A; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany., Dobberkau AM; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany., Weichenhan D; Division of Cancer Epigenomics, DKFZ, Heidelberg, Germany., Plass C; Division of Cancer Epigenomics, DKFZ, Heidelberg, Germany., Hartmann M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany., Diwan GD; Bioquant, Heidelberg University, Heidelberg, Germany.; Heidelberg University Biochemistry Center (BZH), Heidelberg, Germany., Carrero ZI; Department for Translational Medical Oncology, NCT, NCT/UCC Dresden, a Partnership Between DKFZ, Heidelberg Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany., Ball CR; Department for Translational Medical Oncology, NCT, NCT/UCC Dresden, a Partnership Between DKFZ, Heidelberg Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD, Dresden, Germany.; Faculty of Biology, TUD Dresden University of Technology, Dresden, Germany., Hohl T; Division of Applied Functional Genomics, German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Kindler T; University Cancer Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.; Department of Hematology, Medical Oncology and Pneumology, University Medical Center, Mainz, Germany.; German Cancer Consortium (DKTK), Mainz, Germany., Rudolph-Hähnel P; University Cancer Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.; Department of Hematology, Medical Oncology and Pneumology, University Medical Center, Mainz, Germany.; German Cancer Consortium (DKTK), Mainz, Germany., Helm D; Proteomics Core Facility, DKFZ, Heidelberg, Germany., Schneider M; Proteomics Core Facility, DKFZ, Heidelberg, Germany., Nilsson A; Pediatric Oncology and Coagulation, Karolinska University Hospital, Stockholm, Sweden., Øra I; Pediatric Oncology and Hematology, Skåne University Hospital, Lund University, Lund, Sweden., Imle R; Soft-Tissue Sarcoma Junior Research Group, DKFZ, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ) and NCT Heidelberg, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany., Banito A; Soft-Tissue Sarcoma Junior Research Group, DKFZ, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ) and NCT Heidelberg, Heidelberg, Germany., Russell RB; Bioquant, Heidelberg University, Heidelberg, Germany.; Heidelberg University Biochemistry Center (BZH), Heidelberg, Germany., Jones BC; German Cancer Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ) and NCT Heidelberg, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany., Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany., Glimm H; Department for Translational Medical Oncology, NCT, NCT/UCC Dresden, a Partnership Between DKFZ, Heidelberg Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD, Dresden, Germany.; Translational Functional Cancer Genomics, DKFZ, Heidelberg, Germany., Hübschmann D; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg, and DKFZ, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany., Hartmann W; Gerhard Domagk Institute of Pathology, University Hospital Münster, Münster, Germany., Fröhling S; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de., Scholl C; Division of Applied Functional Genomics, German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany. claudia.scholl@nct-heidelberg.de.
Publikováno v:
Nature communications [Nat Commun] 2024 Jan 02; Vol. 15 (1), pp. 51. Date of Electronic Publication: 2024 Jan 02.
Autor:
Mock A; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Pathology, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany., Teleanu MV; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology, Oncology and Rheumatology, Heidelberg Unversity Hospital, Heidelberg, Germany., Kreutzfeldt S; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany., Heilig CE; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany., Hüllein J; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Möhrmann L; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases/University Cancer Center (NCT/UCC) Dresden, Dresden, Germany.; DKFZ, Heidelberg, Germany., Jahn A; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, Technische Universität Dresden and Hereditary Cancer Syndrome Center Dresden, Dresden, Germany., Hanf D; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases/University Cancer Center (NCT/UCC) Dresden, Dresden, Germany.; DKFZ, Heidelberg, Germany., Kerle IA; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases/University Cancer Center (NCT/UCC) Dresden, Dresden, Germany.; DKFZ, Heidelberg, Germany., Singh HM; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany., Hutter B; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Uhrig S; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Fröhlich M; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Neumann O; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Hartig A; Institute of Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Brückmann S; Institute of Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Hirsch S; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany., Grund K; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany., Dikow N; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany., Lipka DB; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Translational Cancer Epigenomics, Division of Translational Medical Oncology, NCT Heidelberg and DKFZ, Heidelberg, Germany., Renner M; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany., Bhatti IA; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany., Apostolidis L; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany., Schlenk RF; Department of Hematology, Oncology and Rheumatology, Heidelberg Unversity Hospital, Heidelberg, Germany.; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.; NCT Trial Center, NCT Heidelberg and DKFZ, Heidelberg, Germany., Schaaf CP; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany., Stenzinger A; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Schröck E; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, Technische Universität Dresden and Hereditary Cancer Syndrome Center Dresden, Dresden, Germany., Hübschmann D; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany., Heining C; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases/University Cancer Center (NCT/UCC) Dresden, Dresden, Germany.; DKFZ, Heidelberg, Germany., Horak P; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany., Glimm H; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases/University Cancer Center (NCT/UCC) Dresden, Dresden, Germany.; DKFZ, Heidelberg, Germany., Fröhling S; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2023 Oct 26; Vol. 7 (1), pp. 109. Date of Electronic Publication: 2023 Oct 26.
Autor:
Weichenhan D; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Riedel A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany., Meinen C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Basic A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Toth R; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Luxembourg Institute of Health, Luxembourg, Luxembourg., Bähr M; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Lutsik P; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Oncology KU Leuven, Leuven, Belgium., Hey J; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany., Sollier E; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany., Toprak UH; Faculty of Biosciences, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany.; Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kelekçi S; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany., Lin YY; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hakobyan M; Faculty of Biosciences, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany.; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Touzart A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Université de Paris Cité, Institut Necker Enfants-Malades (INEM), Institut National de la Santé et de la Recherche Médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France., Goyal A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Wierzbinska JA; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany., Schlesner M; Faculty of Applied Informatics, University of Augsburg, Augsburg, Germany., Westermann F; Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany., Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany. c.plass@dkfz.de.; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. c.plass@dkfz.de.
Publikováno v:
Leukemia [Leukemia] 2023 May; Vol. 37 (5), pp. 1147-1150. Date of Electronic Publication: 2023 Mar 22.
Autor:
Hey J; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Ruprecht Karl University of Heidelberg, Heidelberg, Germany., Halperin C; Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel., Hartmann M; Translational Cancer Epigenomics, Division Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Mayer S; Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel., Schönung M; Faculty of Biosciences, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.; Translational Cancer Epigenomics, Division Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Lipka DB; Translational Cancer Epigenomics, Division Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Scherz-Shouval R; Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel., Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
International journal of cancer [Int J Cancer] 2023 Mar 15; Vol. 152 (6), pp. 1226-1242. Date of Electronic Publication: 2022 Dec 09.
Autor:
Manoochehri M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of In Vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany., Borhani N; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Gerhäuser C; Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Assenov Y; Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Schönung M; Section Translational Cancer Epigenomics, Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Hielscher T; Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Christensen BC; Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA., Lee MK; Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA., Gröne HJ; Department of Pharmacology, University of Marburg, Marburg, Germany., Lipka DB; Section Translational Cancer Epigenomics, Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Brüning T; Institute for Prevention & Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany., Brauch H; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; iFIT Cluster of Excellence, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Tübingen, Germany., Ko YD; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany., Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
International journal of cancer [Int J Cancer] 2023 Mar 01; Vol. 152 (5), pp. 1025-1035. Date of Electronic Publication: 2022 Nov 08.
Autor:
Schönung M; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Hartmann M; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Krämer S; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany; Biomedical Informatics, Data Mining and Data Analytics, Faculty of Applied Computer Science and Medical Faculty, University of Augsburg, Augsburg, Germany., Stäble S; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany., Hakobyan M; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Kleinert E; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany., Aurich T; Division of Experimental Hematology, German Cancer Research Center, Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Cobanoglu D; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany; Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany., Heidel FH; Innere Medizin C, Universitätsmedizin Greifswald, Greifswald, Germany; Leibniz Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany., Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany., Milsom MD; Division of Experimental Hematology, German Cancer Research Center, Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany., Schlesner M; Biomedical Informatics, Data Mining and Data Analytics, Faculty of Applied Computer Science and Medical Faculty, University of Augsburg, Augsburg, Germany., Lutsik P; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany. Electronic address: p.lutsik@dkfz.de., Lipka DB; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany; Faculty of Medicine, Otto-von-Guericke-University, Magdeburg, Germany. Electronic address: d.lipka@dkfz.de.
Publikováno v:
Experimental hematology [Exp Hematol] 2023 Jan; Vol. 117, pp. 24-42.e7. Date of Electronic Publication: 2022 Nov 08.